Alpha-melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes.
Barcellini. W W; Colombo. G G; La Maestra. L L; Clerici. G G; Garofalo. L L; Brini. A T AT; Lipton. J M JM; Catania. A A
Key Findings
- U1 cells naturally make alpha‑MSH; blocking it makes HIV activity go up, suggesting an internal protective loop.
- Adding synthetic alpha‑MSH or the KPV fragment reduces HIV p24 antigen release from infected cells.
- KPV also cuts HIV replication in freshly infected macrophages and does so by inhibiting NF‑kappaB transcriptional activity.
Practical Outcomes
- For biohackers, the study hints that KPV could have antiviral properties, but it’s only been tested in cell cultures. No dosing guidelines, safety data, or human studies exist, so using it outside a research setting would be speculative and potentially risky.
Summary
Researchers found that a tiny piece of the hormone alpha‑MSH, called KPV, can lower HIV virus activity in lab-grown immune cells. The peptide seems to work by blocking a cell signal (NF‑kappaB) that the virus uses to replicate. While the effect is clear in test tubes, there’s no data yet on safety or effectiveness in people.
Abstract
The purpose of the present research was to determine if alpha-melanocyte-stimulating hormone (alpha-MSH) and its C-terminal tripeptide [alpha-MSH (11-13), KPV] alter HIV expression in infected cells. The results indicate that chronically HIV-1-infected promonocytic U1 cells produce alpha-MSH and that immunoneutralization of the endogenous peptide enhances HIV expression. Because U1 cells express the alpha-MSH receptor 1 (MC1R), an autocrine-inhibitory circuit based on the peptide and its receptor likely occurs in these cells. To determine effects of pharmacological concentrations of alpha-MSH peptides on HIV expression, we measured p24 antigen release by TNF-alpha-stimulated U1 cells exposed to a wide range of concentrations of synthetic alpha-MSH and KPV. Viral expression was reduced by both peptides. KPV also effectively reduced HIV replication in acutely infected monocyte-derived macrophages (MDM). The basis of the peptide influence on viral replication is at the transcriptional level; KPV inhibited activation of NF-kappaB that is known to enhance viral expression. Endogenous alpha-MSH likely contributes to natural defense against HIV. However, greater concentrations of synthetic peptide are much more effective in reducing HIV expression in infected cells.
Study Information
pubmed
2000